Federal Supply Schedule 36F79720D0136
Award Date
6/1/20
Last Date to Order
12/31/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Ferring Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) has awarded a single-award Blanket Purchase Agreement (BPA) to Ferring Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The $5.96 million BPA, with a period of performance through March 2026, enables the VA to procure the drug Adstiladrin (nadofaragene firadenovec), a treatment for genitourinary cancers, to support the provision of healthcare services to...
The Department of Veterans Affairs (VA) has awarded Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., a $3.1 billion multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). This contract, valid through August 2029, enables the VA and its Veterans Integrated Service Networks (VISNs) to efficiently procure a variety of oncology and specialty medications to support comprehensive healthcare services for veteran patients nationwide. Under...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract (36F79723D0079) to Fennec Pharmaceuticals, Inc., a foreign-owned, for-profit pharmaceutical company. This multiple-award contract has a ceiling value of $1,500,000 and a period of performance through February 29, 2028. It covers the provision of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB, intended to ensure VA medical centers and...
The Department of Veterans Affairs (VA) has awarded a $19.3 million Federal Supply Schedule (FSS) contract to Servier Pharmaceuticals LLC, a for-profit pharmaceutical company, to provide drugs, pharmaceuticals, and hematology-related products under the FSS-61-IB schedule. This multiple-award contract has a period of performance through September 2025. The VA has placed several firm-fixed price delivery orders against this FSS contract for Servier to supply specialty oncology medications such...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
The Department of Veterans Affairs (VA) has awarded a $5.4 billion Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical products. This IDV contract enables Novartis to provide a comprehensive range of pharmaceutical and drug products to support VA medical programs. Under this FSS contract, the VA has issued multiple delivery orders to Novartis for specialized cancer...
The Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract, valued at up to $3.5 million, to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company. The contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, facilitates the procurement of TARPEYO, an innovative treatment for uncontrolled protein in urine due to primary immunoglobulin A nephropathy, a serious renal condition impacting some veterans. In addition to the FSS...
The U.S. Department of Veterans Affairs (VA) awarded Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer, a $15.6 million multiple-award Federal Supply Schedule (FSS-61-IB) contract and a $3.1 million single-award Blanket Purchase Agreement to supply specialized orphan drugs and rare disease treatments. The contract vehicles allow the VA to efficiently procure Recordati's portfolio of medications, including Signifor LAR, Carbaglu, Cystadane, Isturisa, and Cystadrops,...
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract, identified as 36F79720D0075, to Vifor (International) AG, a Swiss-based pharmaceutical manufacturer. The contract, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), enables the VA to efficiently procure critical pharmaceutical products to support healthcare for veterans. Through this contract, Vifor (International) AG has received multiple delivery orders to supply various...
The federal contract IDV is a Federal Supply Schedule (FSS) contract (36F79723D006E) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 to Fennec Pharmaceuticals, Inc. The contract is an interim agreement under FSS Schedule 65 IB, which covers drugs, pharmaceuticals, and hematology-related products, with a ceiling value of $25,000 and a period of performance through May 30, 2023. This IDV supports the VA's objective of providing veterans with timely...